These InformationWeek 500 innovators are trying
unique approaches to solve business problems. Could
your company use a few extra bright ideas?
5 of 20
In developing new drugs, Eli Lilly devotes significant time to drug and disease modeling. Before its Modeling and Simulation Explorer effort, referred to as MuSE, generating and packaging simulation results was a manual process that took a significant amount of modeling experts' time.
MuSE created an interactive environment that makes it possible to extract and visualize model-derived information in real time. This information makes it easier to pick drug compounds and doses, as well as to optimize study designs.
Executing simulations and compiling results, which previously required days or weeks of modeling experts' time, can now be done in minutes. And Lilly clinical trial designs are benefiting from improved dose/response relationships, better trial dose starting points, and the ability to simulate multiple trial endpoints. All of these contribute to more efficient clinical trials with fewer failed designs.
IT's Reputation: What the Data SaysInformationWeek's IT Perception Survey seeks to quantify how IT thinks it's doing versus how the business really views IT's performance in delivering services - and, more important, powering innovation. Our results suggest IT leaders should worry less about whether they're getting enough resources and more about the relationships they have with business unit peers.
What The Business Really Thinks Of IT: 3 Hard TruthsThey say perception is reality. If so, many in-house IT departments have reason to worry. InformationWeek's IT Perception Survey seeks to quantify how IT thinks it's doing versus how the business views IT's performance in delivering services - and, more important, powering innovation. The news isn't great.